These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6129634)

  • 1. The antagonism between botulinum toxin and calcium in motor nerve terminals.
    Gundersen CB; Katz B; Miledi R
    Proc R Soc Lond B Biol Sci; 1982 Oct; 216(1204):369-76. PubMed ID: 6129634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of packets of acetylcholine and synaptic vesicle elicited by brown widow spider venom in frog motor nerve endings poisoned by botulinum toxin.
    Pumplin DW; del Castillo J
    Life Sci; 1975 Jul; 17(1):137-41. PubMed ID: 1079912
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.
    Molgó J; Siegel LS; Tabti N; Thesleff S
    J Physiol; 1989 Apr; 411():195-205. PubMed ID: 2575665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reduction of endplate responses by botulinum toxin.
    Gundersen CB; Katz B; Miledi R
    Proc R Soc Lond B Biol Sci; 1981 Nov; 213(1193):489-93. PubMed ID: 6119693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In botulinum type A-poisoned frog motor endings ouabain induces phasic transmitter release through Na+-Ca2+ exchange.
    Molgo J; Angaut-Petit D; Thesleff S
    Brain Res; 1987 May; 410(2):385-9. PubMed ID: 3036311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine.
    Lundh H; Leander S; Thesleff S
    J Neurol Sci; 1977 May; 32(1):29-43. PubMed ID: 194021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features.
    Angaut-Petit D; Molgó J; Comella JX; Faille L; Tabti N
    Neuroscience; 1990; 37(3):799-808. PubMed ID: 1701041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of type D botulinum toxin on frog neuromuscular junctions.
    Harris AJ; Miledi R
    J Physiol; 1971 Sep; 217(2):497-515. PubMed ID: 4329008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions.
    Comella JX; Molgo J; Faille L
    Neurosci Lett; 1993 Apr; 153(1):61-4. PubMed ID: 8390032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the functional neuromuscular transmission unit.
    Stokes HB
    J Tenn Med Assoc; 1974 May; 67(5):399-403. PubMed ID: 4367687
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the internal calcium regulation altered in type A botulinum toxin-poisoned motor endings?
    Mallart A; Molgó J; Angaut-Petit D; Thesleff S
    Brain Res; 1989 Feb; 479(1):167-71. PubMed ID: 2538205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of implantation of an extra nerve on the recovery of neuromuscular transmission from botulinum toxin.
    Tonge DA
    J Physiol; 1977 Mar; 265(3):809-20. PubMed ID: 192880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sprouting of frog motor nerve terminals after long-term paralysis by botulinum type A toxin.
    Diaz J; Molgó J; Pécot-Dechavassine M
    Neurosci Lett; 1989 Jan; 96(2):127-32. PubMed ID: 2784552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of blockade of neuromuscular transmission by botulinum toxins on the sensitivity of skeletal muscle to acetylcholine in the frog [proceedings].
    Tonge DA; Wernig A
    J Physiol; 1978 Jul; 280():11P. PubMed ID: 211225
    [No Abstract]   [Full Text] [Related]  

  • 15. Restoration of transmitter release in botulinum-poisoned skeletal muscle.
    Lundh H; Cull-Candy SG; Leander S; Thesleff S
    Brain Res; 1976 Jun; 110(1):194-8. PubMed ID: 6127
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of action potentials in frog slow muscle fibres paralysed by botulinum toxin.
    Miledi R; Spitzer NC
    J Physiol; 1974 Aug; 241(1):183-99. PubMed ID: 4371279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin: mechanism of presynaptic blockade.
    Kao I; Drachman DB; Price DL
    Science; 1976 Sep; 193(4259):1256-8. PubMed ID: 785600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of botulinum toxin and the effect of drug antagonists.
    Thesleff S; Lundh H
    Adv Cytopharmacol; 1979; 3():35-43. PubMed ID: 38651
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of calcium channel blockaders (verapamil, D-600 and manganese ions) on mediator release from frog muscle motor nerve endings].
    Gotgil'f NM; Magazanik LG
    Neirofiziologiia; 1977; 9(4):415-22. PubMed ID: 302922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
    Coffield JA; Bakry NM; Maksymowych AB; Simpson LL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.